| Patient | Alan Turing |
|---|---|
| Date of birth | 1985-06-23 |
| Identifiers | MRN HR-ML007-SYN; SSN (made up) 000-07-6290 |
| Document date | 2026-10-20 |
| Author | Rupert Hallam, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic preventive visit; no new complaints. [S]
Mr. Turing is a 41-year-old mathematician who comes for his periodic preventive visit two weeks after his six-month review. He completed the health risk assessment before the visit. His ankle recovered within three weeks of the August visit; he took ibuprofen for four days and is back to about 40 km a week. His depression is in remission on bupropion XL 150 mg with monthly psychotherapy sessions, and his testosterone has been normal since August. The breast tissue is no longer tender. He has had no suicidal thoughts. He has not had HIV or STI testing since moving here and would like it today. He has had one new male partner in the past three months and uses condoms most of the time. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 41 |
| Safety events | No falls, emergency visits, or hospital stays this year |
| Medicines | Bupropion XL 150 mg and cholecalciferol 1,000 units daily; ibuprofen for four days in August |
| Active conditions | Depression in remission; small residual gynecomastia; ankle sprain resolved |
| Sexual health | One new male partner in three months; condoms most of the time; asks for HIV and STI testing |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, much better than in the spring |
| Psychosocial | Sees friends weekly; back with his running club; no current legal proceedings |
| Tobacco | Never used tobacco |
| Alcohol and drugs | Two or three drinks a week (AUDIT-C 2); no drug use |
| Physical activity | Running about 40 km a week with weekly strength work |
| Nutrition | Regular meals; calcium from dairy most days |
| Sleep | About seven hours a night |
| Sexual health | One new male partner in the past three months; condoms most of the time; no symptoms |
| Activities of daily living | Independent |
| Instrumental activities of daily living | Independent |
| Home safety | Smoke detectors working; no firearms in the home |
| Hearing and vision | No concerns |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight steady; no fever or fatigue |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No hearing loss, sore throat, or mouth ulcers |
| Cardiovascular | Negative | No chest pain or palpitations when running |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No abdominal pain, change in bowel habit, or rectal symptoms |
| Genitourinary | Negative | No urethral discharge, dysuria, or genital sores; libido and erections back to his usual |
| Musculoskeletal | Negative | Ankle recovered |
| Integumentary | Negative | No rash or new skin lesions |
| Neurological | Negative | No headaches or numbness |
| Psychiatric | Negative | Mood good; PHQ-9 3 with item 9 scored 0; no suicidal thoughts |
| Breast | Negative | No breast pain, new lump, or nipple discharge |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cholecalciferol 1,000 units (25 mcg) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-04-14 | active | S |
| Bupropion extended-release 150 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 2026-06-09 | active | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth up to three times a day with food for no more than 5 days | One tablet up to three times a day with food, for no more than 5 days | Oral route | 2026-08-25 to 2026-08-30 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-20 | Body height | 178 | cm | S |
| 2026-10-20 | Body weight | 68.5 | kg | S |
| 2026-10-20 | Body mass index (BMI) [Ratio] | 21.6 | kg/m2 | S |
| 2026-10-20 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-10-20 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-10-20 | Heart rate | 54 | /min | S |
| 2026-10-20 | Respiratory rate | 14 | /min | S |
| 2026-10-20 | Body temperature | 36.6 | Cel | S |
| 2026-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-10-20 | Total score [AUDIT-C] | 2 | {score} | S | ||
| 2026-10-20 | Cholesterol [Mass/volume] in Serum or Plasma | 182 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-10-20 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 62 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-10-20 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 104 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-10-20 | Triglyceride [Mass/volume] in Serum or Plasma | 80 | mg/dL | <=149 mg/dL | Normal | S |
Vital signs recorded on 2026-10-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well and lean; weight 68.5 kg, BMI 21.6 |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm at 54 per minute, as expected in a trained runner; no murmur |
| Respiratory | Clear |
| Breast | Examined with his agreement: a soft disc of glandular tissue about 2 cm behind the left nipple and 1 cm behind the right, non-tender; no discrete mass, skin change, nipple discharge, or axillary nodes |
| Abdomen | Soft and non-tender |
| Genitourinary | Offered and declined today; no symptoms |
| Skin | No rash or suspicious lesions |
| Musculoskeletal | Right ankle stable with full range of motion |
| Mental status | Relaxed, humorous, and engaged; euthymic; no suicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Bilateral gynecomastia, tender, about 4 cm of firm glandular tissue behind each nipple, after a year of high-dose estrogen; synthetic modern diagnosis linked to the documented breast growth from his hormone treatment | active | confirmed | N62 | S — Synthetic modern diagnosis. That the hormone treatment caused breast growth is reported in the sources (D, mentioned once in his own words); the examination findings are synthetic. |
| Suppressed testosterone and gonadotropins from exogenous estrogen (drug-induced hypogonadotropic hypogonadism), with low libido, erectile difficulty, and fatigue | resolved | confirmed | E23.1 | S — Synthetic consequence of high-dose estrogen, which suppresses LH and FSH; recovery is expected once it stops. |
| Adverse effects of high-dose estrogen given for a year without free and informed consent, as the alternative to imprisonment | active | confirmed | T38.5X5A | S — Synthetic modern framing of the documented hormone treatment imposed after his conviction (D); in the modern episode it is recorded as iatrogenic harm. |
| Major depressive disorder, single episode, moderate, after prosecution and coerced hormone treatment; synthetic modern diagnosis (no depression diagnosis is documented in his lifetime) | active | confirmed | F32.1 | S — Synthetic modern diagnosis. That he sought Jungian analysis after the trial is documented (D); calling his state then a depressive illness is a retrospective interpretation (R). |
| Vitamin D insufficiency (25-hydroxyvitamin D 22 ng/mL) | resolved | confirmed | E55.9 | S — Synthetic finding of the bone-health workup. |
| Right lateral ankle sprain while trail running, able to bear weight, Ottawa ankle rules negative; resolved | resolved | confirmed | S93.401A | S — Synthetic sprain at an unscheduled visit, chosen to teach the Ottawa ankle rules and how to protect a depression plan that relies on running; it does not echo any documented injury. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 116/72 mmHg |
| Cholesterol and statin decision | Completed today | Total cholesterol 182, HDL 62, LDL 104, triglycerides 80 mg/dL; ten-year risk under 2 percent, so no statin; repeat in five years |
| Diabetes screening | Not indicated | BMI 21.6 with no other risk factors; screening is for adults 35 to 70 with overweight or obesity |
| HIV screening | Ordered | HIV antigen and antibody test drawn today with his consent |
| Syphilis, gonorrhea, and chlamydia testing | Ordered | Syphilis serology and urine, pharyngeal, and rectal NAATs by site of exposure, drawn today with his consent; yearly while sexually active, more often if his risk changes |
| Hepatitis C screening | Ordered | One-time antibody test drawn today |
| Hepatitis B screening and vaccination | Ordered | HBsAg, core antibody, and surface antibody drawn today; vaccinate if not immune |
| HIV preexposure prophylaxis | Not indicated | Discussed as routine care; he does not meet the indications now; to be revisited at any visit he wishes |
| Colorectal cancer screening | Not indicated | Begins at 45; no family history recorded |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never used tobacco |
| Depression screening and monitoring | Completed today | PHQ-9 3 in continuation treatment; item 9 scored 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 2 |
| Influenza vaccine, this season | Completed today | Given today with his consent |
| COVID-19 vaccine, this season | Due | Recommended; he will have it at a pharmacy next week |
| Hepatitis A vaccine | Due | Recommended for men who have sex with men; first dose at his next visit after he has thought it over |
| HPV vaccine | Due | Shared decision for adults 27 to 45; he will decide at his next visit |
| Tetanus, diphtheria, and pertussis booster | Up to date | Tdap five years ago |
| Dental examination | Due | No dental visit since moving here; he will book one |
Immunizations given today: Influenza vaccine, 2026-2027 season [S]
Guideline basis: APA Guidelines for Psychological Practice With Sexual Minority Persons (2021); Sexually Transmitted Infections Treatment Guidelines: Men Who Have Sex with Men (2021); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Results by secure message within a week. COVID-19 vaccine at a pharmacy. Hepatitis A and HPV vaccine decisions at the next visit. Depression review in about two months. Next preventive visit in one year. [S]
Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, a close friend, and completed a health care proxy form; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think and work, and that no treatment should ever be given to him without his own agreement or, if he cannot speak, his agent's. He wants full treatment for reversible illness. He asked that his records, including his sexual orientation and the history of the estrogen he was given, be shared only with clinicians treating him. The plan will be revisited yearly. [S]